The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma

Iacovelli R;Rocca MC;Galli L;Sabbatini R;De Giorgi U;Santini D;Facchini G;Mosca A;Atzori F;Zucali P;Fornarini G;Massari F;Buti S;Ricotta R;Masini C;Toscani I;Biasco E;Guida A;Lolli C;De Lisi D;Rossetti S;Terrone C;Scartozzi M;Miggiano C;Pastorino A;Bersanelli M;Carlo-Stella G;Pinto C;Nobili E;Nole F;Tortora G;Porta C

2018-01-01